Artículos del autor

solaci

Institutional News

The Most Important Articles of 2022 in Coronary disease

Discover the most important scientific articles of 2022on coronary disease in our website. An Abbreviated Dual Antiplatelet Regimen...
solaci -
Institutional News

The Most Important Articles of 2022 in Structural Heart Disease

Discover the most read scientific articles on interventional cardiology of 2022 in our website. We Should Treat Significant...
solaci -
Acute coronary syndromes

Can We Use DAPT for 3 Months in Acute Coronary Syndrome?

Current guidelines recommend 12-month dual antiplatelet therapy (DAPT) after DES stenting for acute coronary syndrome (ACS) because...
solaci -
Chronic Ischemic cardiopathy

Hybrid Coronary Revascularization: A Valid Option?

In this article, we will examine the use of hybrid coronary revascularization to treat multivessel coronary artery...
solaci -
Coronary disease

Real-World Revascularization Strategy for Left Main Coronary Artery: Surgery or PCI?

There are many current randomized trials comparing percutaneous coronary intervention (PCI) with myocardial revascularization surgery (MRS) for...
solaci -
Acute coronary syndromes

Invasive Myocardial Viability Indexes

From a cellular standpoint, the term ‘myocardial viability’ refers to a myocyte that has no irreparable damage....
solaci -
Mitral valve

Secondary Mitral Regurgitation: Stages of Heart Failure and Prognostic Implications after Transcatheter Edge-to-Edge Repair

We are already familiar with the strong impact of secondary mitral valve regurgitation (SMR) in survival and...
solaci -
Institutional News

Interventional cardiology: the most read articles of 2022 in solaci.org

Discover the most read scientific articles on interventional cardiology of 2022 in our website. The FDA Approves Intravascular...
solaci -